Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Immunotherapy of Natural Killer in HTLV-1 Associated Myelopathy
Brief Summary: HTLV-1 Associated Myelopathy is a chronic disease of the spinal cord, caused by a virus called human T lymphotropic virus type 1（HTLV−1）. Natural Killer cells provide rapid responses to viral-infected cells, acting at around 3 days after infection, and respond to tumor formation. In this trial, the investigators aim to study the therapeutic safety and the effect on HTLV-1 virus. This in turn will improve the knowledge and understanding of the disease and should lead to better therapy.